GlassScriptPhysician profile
Zain Abidi
NPI 1316575863
$2,218.96
in general payments reported to CMS, 2019-2025
13 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.18 · 2022: $37.56 · 2023: $250 · 2024: $309 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Travel and Lodging: $809 · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.79 |
| Travel and Lodging | $809.06 |
| Education | $217.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,211.21 | 2023-2025 | Corevalve Evolut R, Endurant Iis, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $359.81 | 2025 | Ensite, Aveir |
| Silk Road Medical, INC. | $129.21 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abiomed | $119.55 | 2025 | |
| Biotronik INC. | $116.44 | 2025 | Selectra |
| United Therapeutics Corporation | $109.50 | 2025 | |
| Abbvie INC. | $37.56 | 2022 | |
| Pfizer INC. | $30.29 | 2023 | |
| Genzyme Corporation | $27.18 | 2021 | |
| Boston Scientific Corporation | $24.24 | 2023 | Latitude Communicator Power Supply |
| Merck Sharp & Dohme LLC | $20.81 | 2025 | Verquvo |
| Cordis US Corp. | $20.24 | 2024 | Mynx Venous Vcd |
| Kiniksa Pharmaceuticals, LTD. | $12.92 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zain Abidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.